Nu-Med Plus, Inc. (NUMD): Completion of Acquisition or Disposition of Assets
Nu-Med Plus, Inc. (NUMD) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.3 4 numd003_ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 VOTING AGREEMENT THIS VOTING AGREEMENT , dated July 9, 2026 and effective July 8, 2026 (the “ Effective Date ”) (this “ Agreement ”), is made by and among the person(s) executing this Agreement listed on the signature page he
How this was made
The 30-second read
Why it matters
Completion of the acquisition/disposition plus planned corporate actions (authorized share increase, 1-for-27 reverse split, redomiciliation to Nevada, and name change) can materially alter the company’s capital structure and governance, affecting valuation, liquidity, and trading behavior.
Market read
This is a company-specific post-close disclosure with explicit corporate-action mechanics that can create near-term trading volatility and require traders to adjust for reverse split and redomiciliation timelines.
What to watch
Traders should focus on the missing deal consideration, post-close share count, and whether the reverse split is already effective or requires additional approvals and timing details not shown here.
Background
The 8-K includes a voting agreement tied to a share exchange involving Nu-Med Plus and Avid Gold, plus binding votes for director elections and several corporate actions.
Ticker impact
Nu-Med Plus files an 8-K stating completion of an acquisition/disposition and includes voting terms tied to a share exchange and corporate actions.
Likely elevated volatility around corporate-action mechanics and any subsequent trading resumption, with direction dependent on deal economics not provided here.
The text confirms completion of the asset transaction and describes binding voting support for reverse split and redomiciliation, both of which typically affect liquidity, float, and investor perception. However, deal consideration and post-close financial impact are not included in the excerpt.
Market effects
Limited read-across; this is company-specific restructuring and capital-structure change rather than a sector-wide signal.
No clear regional spillover indicated in the excerpt.
Low; transaction appears domestic with a UK entity referenced only as a counterparty in the voting agreement.
Counterpoint
Reverse splits and redomiciliation can be purely administrative to facilitate the transaction, so the market reaction may be muted if investors view the deal as already priced.
Key entities
- issuerNu-Med Plus, Inc.
Subject of the SEC 8-K, reporting completion of acquisition/disposition and related governance/corporate-action voting terms.
- counterpartyAvid Gold Ltd
Referenced in the voting agreement as the entity whose stockholders designate directors and are part of the underlying exchange agreement.
